» Articles » PMID: 23076628

Activation of PARP by Oxidative Stress Induced by β-amyloid: Implications for Alzheimer's Disease

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2012 Oct 19
PMID 23076628
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a major neurodegenerative disease of old age, characterised by progressive cognitive impairment, dementia and atrophy of the central nervous system. The pathological hallmarks include the accumulation of the peptide β-amyloid (Aβ) which itself is toxic to neurons in culture. Recently, it has been discovered that Aβ activates the protein poly(ADP-ribosyl) polymerase-1 (PARP-1) specifically in astrocytes, leading indirectly to neuronal cell death. PARP-1 is a DNA repair enzyme, normally activated by single strand breaks associated with oxidative stress, which catalyses the formation of poly ADP-ribose polymers from nicotinamide adenine dinucleotide (NAD(+)). The pathological over activation of PARP-1 causes depletion of NAD(+) and leads to cell death. Here we review the relationship between AD and PARP-1, and explore the role played by astrocytes in neuronal death. AD has so far proven refractory to any effective treatment. Identification of these pathways represents a step towards a greater understanding of the pathophysiology of this devastating disease with the potential to explore novel therapeutic targets.

Citing Articles

Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer's disease.

Fine J, Kosyakovsky J, Bowe T, Faltesek K, Stroebel B, Abrahante J Front Neurosci. 2025; 18:1528374.

PMID: 39872995 PMC: 11770042. DOI: 10.3389/fnins.2024.1528374.


Proteins Associated with Neurodegenerative Diseases: Link to DNA Repair.

Khodyreva S, Dyrkheeva N, Lavrik O Biomedicines. 2025; 12(12.

PMID: 39767715 PMC: 11673744. DOI: 10.3390/biomedicines12122808.


Mitochondrial One-Carbon Metabolism and Alzheimer's Disease.

Yu Y, Martins L Int J Mol Sci. 2024; 25(12).

PMID: 38928008 PMC: 11203557. DOI: 10.3390/ijms25126302.


Effects of amyloid-β-mimicking peptide hydrogel matrix on neuronal progenitor cell phenotype.

Mathes T, Monirizad M, Ermis M, de Barros N, Rodriguez M, Kraatz H Acta Biomater. 2024; 183:89-100.

PMID: 38801867 PMC: 11239292. DOI: 10.1016/j.actbio.2024.05.020.


Poly-(ADP-ribose) polymerases inhibition by olaparib attenuates activities of the NLRP3 inflammasome and of NF-κB in THP-1 monocytes.

Mustafa K, Han Y, He D, Wang Y, Niu N, Jose P PLoS One. 2024; 19(2):e0295837.

PMID: 38335214 PMC: 10857571. DOI: 10.1371/journal.pone.0295837.


References
1.
Mandir A, Przedborski S, Jackson-Lewis V, Wang Z, Simbulan-Rosenthal C, Smulson M . Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci U S A. 1999; 96(10):5774-9. PMC: 21936. DOI: 10.1073/pnas.96.10.5774. View

2.
Chung Y, Joo K, Lee Y, Shin D, Cha C . Reactive astrocytes express PARP in the central nervous system of SOD(G93A) transgenic mice. Brain Res. 2004; 1003(1-2):199-204. DOI: 10.1016/j.brainres.2004.01.010. View

3.
Canevari L, Abramov A, Duchen M . Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress. Neurochem Res. 2004; 29(3):637-50. DOI: 10.1023/b:nere.0000014834.06405.af. View

4.
Corona C, Pensalfini A, Frazzini V, Sensi S . New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc. Cell Death Dis. 2011; 2:e176. PMC: 3168999. DOI: 10.1038/cddis.2011.57. View

5.
Blass J, Gibson G . The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev Neurol (Paris). 1991; 147(6-7):513-25. View